By
Drug Target Review2025-01-14T08:00:59
A new study demonstrates how neurotransmitters affect brain gene expression, offering potential therapeutic insights for circadian rhythm disorders.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-12T09:31:00Z
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2023-03-20T13:41:33
Sponsored by Bio-Techne
2023-07-03T10:28:23
Sponsored by Merck
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-03-30T09:15:30
Sponsored by Halo Labs
2024-01-19T07:40:55
Sponsored by Euretos
Site powered by Webvision Cloud